Literature DB >> 18000610

Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.

Peter K Henke1, Manu R Varma, Daria K Moaveni, Nicholas A Dewyer, Andrea J Moore, Erin M Lynch, Christopher Longo, C Barry Deatrick, Steven L Kunkel, Gilbert R Upchurch, Thomas W Wakefield.   

Abstract

Vessel wall matrix changes occur after injury, although this has not been well studied in the venous system. This study tested the hypothesis that the thrombus dictates the vein wall response and vein wall damage is directly related to the duration of thrombus contact. To determine the injury response over time, rats underwent inferior vena cava (IVC) ligation to produce a stasis thrombus, with harvest at various time points to 28 days (d). Significant vein wall matrix changes occurred with biomechanical injury (stiffness) peaking at 7-14 d, with concurrent early reduction in total collagen, an increase in early matrix metalloproteinase (MMP)-9 and late MMP-2, and concomitant increase in tumor necrosis factor (TNF)alpha, monocyte chemoattractant(MCP)-1 and tumor growth factor (TGF)beta (all P<0.05). To isolate the effect of the thrombus and its mechanism of genesis, rats underwent 7 d or limited stasis (24 hours), non-stasis thrombosis, or non-thrombotic IVC occlusion (Silicone plug). Vein wall stiffness was increased seven-fold, with a five-fold reduction in collagen, and 5.5- to seven-fold increase in TNFalpha, MCP-1, and TGFbeta with 7 d stasis as compared with controls (all P<0.05). By Picosirus red staining analysis, collagenolysis was significantly greater with 7 d stasis injury (P=0.01) but neither MMP-9 nor MMP-2 activity correlated with injury mechanism. In addition, vein wall cellular proliferation and uPA gene expression paralled the stasis thrombotic injury. Limited stasis, non-stasis thrombosis and non-thrombotic IVC occlusion showed a lesser inflammatory response. These data suggest both a static component and the thrombus directs vein wall injury via multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000610

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

1.  AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.

Authors:  Wanmu Xie; Lin Zhang; Wei Luo; Zhenguo Zhai; Chen Wang; Ying H Shen
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

2.  Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.

Authors:  Nicholas A Dewyer; Osama M El-Sayed; Catherine E Luke; Megan Elfline; Nicolai Kittan; Ron Allen; Adriana Laser; Carson Oostra; Anthony Comerota; Cory Hogaboam; Steven L Kunkel; Peter K Henke
Journal:  Thromb Haemost       Date:  2015-07-16       Impact factor: 5.249

3.  Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.

Authors:  Mizuho Nosaka; Yuko Ishida; Akihiko Kimura; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2010-07-10       Impact factor: 2.686

4.  Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice.

Authors:  Osama M El-Sayed; Nicholas A Dewyer; Catherine E Luke; Megan Elfline; Adriana Laser; Cory Hogaboam; Steven L Kunkel; Peter K Henke
Journal:  J Vasc Surg       Date:  2015-10-23       Impact factor: 4.268

5.  Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.

Authors:  Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Chase W Kessinger; Megan Elfline; Cathy Luke; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

6.  Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.

Authors:  Vikram Sood; Cathy Luke; Erin Miller; Mayo Mitsuya; Gilbert R Upchurch; Thomas W Wakefield; Dan D Myers; Peter K Henke
Journal:  Ann Vasc Surg       Date:  2010-02       Impact factor: 1.466

7.  Postthrombotic vein wall remodeling: preliminary observations.

Authors:  Kristopher B Deatrick; Megan Elfline; Nichole Baker; Catherine E Luke; Susan Blackburn; Catherine Stabler; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2010-09-24       Impact factor: 4.268

8.  Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.

Authors:  Adriana Laser; Megan Elfline; Cathy Luke; Dallas Slack; Anuj Shah; Vikram Sood; Barry Deatrick; Brendan McEvoy; Carson Ostra; Anthony Comerota; Steven Kunkel; Cory Hogaboam; Peter K Henke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-05       Impact factor: 8.311

Review 9.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

Authors:  Kristopher B Deatrick; Catherine E Luke; Megan A Elfline; Vikram Sood; Joseph Baldwin; Gilbert R Upchurch; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2013-03-13       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.